Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities

D. De*, A. Kaushik, S. Handa, R. Mahajan, E. Schmidt

*Corresponding author for this work
Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology
Issue number7
Pages (from-to)e469-e472
Number of pages4
Publication statusPublished - 07.2021

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this